Highlighting this complexity, the latest KDIGO guidelines on anaemia management emphasize that ‘the accuracy of projection (extrapolation) increases with the number of contributing data points, and the frequency of Hb monitoring is likely to be an important determinant of the accuracy of ESA dose adjustment’ [5]. This evidence concerns the gene GSTM1 and anemia (phenotype).